ADC Therapeutics SAADCT
紐約證券 · USD
3.07
-0.18
(-5.54%)
收盤 08/30 03:59 (UTC+8)
08/30 03:59 (UTC+8)
ADC Therapeutics SAADCT
3.07
-0.18
(-5.54%)
財務數據
損益表
- 0.19
- 0.19
- 0.14
- 0.17
- 0.18
- 0.17
- 0.18
- 0.17
- 0.23
- 0.19
- -72.79
- 1.53
- -24.84
- 15.85
- 7.52
- -3.56
- 6.05
- -8.42
- 36.21
- -18.21
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | |
營業收入淨額 | 18,839 | 23,033 | 16,910 | 18,464 | 17,410 | 18,053 | 16,790 | 14,493 | 19,283 | 18,992 |
營業成本 | 836 | 2,061 | 1,371 | 851 | 1,217 | 2,510 | 254 | 208 | 1,132 | -27 |
營業毛利 | 18,003 | 20,972 | 15,539 | 17,613 | 16,193 | 15,543 | 16,536 | 14,285 | 18,151 | 19,019 |
營業費用 | 48,578 | 49,436 | - | - | 45,234 | - | 53,521 | 50,190 | 57,485 | 69,089 |
研發費用 | 30,090 | 28,928 | 27,101 | 32,502 | 24,295 | 25,735 | 27,263 | 27,080 | 31,342 | 38,375 |
推銷及管理費用 | 18,969 | 20,508 | 20,874 | 20,675 | 20,939 | 23,421 | 26,494 | 23,354 | 26,458 | 30,854 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | 4,881 | - |
營業利益 | -30,575 | -28,464 | -32,436 | -35,564 | -29,041 | -33,613 | -36,985 | -35,905 | -39,334 | -50,070 |
其他收入及費用 | - | 2,257 | 13,307 | 5,062 | 6,007 | 353 | - | - | - | - |
利息費用 | 12,997 | 12,230 | 11,919 | 13,117 | 12,679 | 12,496 | 7,675 | 12,816 | 10,309 | 10,291 |
稅前純益 | -55,392 | -38,437 | -31,048 | -43,619 | -35,713 | -45,756 | -34,111 | -45,402 | -52,653 | -57,493 |
所得稅 | 1,254 | 165 | -321 | 90 | 234 | 163 | 46,064 | -85 | -4,498 | 518 |
稅後純益 | -56,646 | -38,602 | -30,727 | -43,969 | -36,544 | -46,606 | -85,703 | -46,726 | -48,922 | -59,374 |
基本每股稅後盈餘(元) | -0.50 | -0.36 | -0.29 | -0.42 | -0.38 | -0.56 | - | -0.57 | -0.60 | -0.73 |
稀釋每股稅後盈餘(元) | -0.50 | -0.36 | -0.27 | -0.42 | -0.37 | -0.56 | - | -0.57 | -0.60 | -0.73 |
基本平均股數(千股) | 113743.00 | 107202.00 | 105396.00 | 104824.00 | 95691.00 | 82552.00 | - | 82256.00 | 81471.00 | 80805.00 |
稀釋平均股數(千股) | 113743.00 | 107202.00 | 105396.00 | 104824.00 | 95691.00 | 82552.00 | - | 82256.00 | 81471.00 | 80805.00 |
還原基本每股稅後盈餘(元) | -0.50 | -0.36 | -0.29 | -0.42 | -0.38 | -0.56 | - | -0.57 | -0.60 | -0.73 |
還原稀釋每股稅後盈餘(元) | -0.50 | -0.36 | -0.27 | -0.42 | -0.37 | -0.56 | - | -0.57 | -0.60 | -0.73 |
還原基本平均股數(千股) | 113,743 | 107,202 | 105,396 | 104,824 | 95,691 | 82,552 | - | 82,256 | 81,471 | 80,805 |
還原稀釋平均股數(千股) | 113,743 | 107,202 | 105,396 | 104,824 | 95,691 | 82,552 | - | 82,256 | 81,471 | 80,805 |
EBITDA(千元) | -41,555 | -18,146 | -11,633 | -22,270 | -15,427 | -25,737 | -30,953 | -33,110 | -42,299 | -47,842 |